An unusual case of dermatitis factitia.
Explore the source record for details and available documents.
Dermatitis↗
SEARCH · PubMed Health
Results for “DERMATITIS FACTITIA”
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
On Zimmerman's "Dermatitis factitia as a war weapon".
Explore the source record for details and available documents.
Dermatitis↗
Dermatitis factitia as a war weapon.
Explore the source record for details and available documents.
Dermatitis↗
Hysterical dermatitis factitia.
Explore the source record for details and available documents.
Abdomen↗
Porphyria cutanea tarda simulating dermatitis factitia; report of a case.
Explore the source record for details and available documents.
Dermatitis↗
[Dermatitis factitia. Psychological and dermatological aspects of a case].
Explore the source record for details and available documents.
Child↗
Cutaneous necrotizing vasculitis after low dose methotrexate therapy for rheumatoid arthritis: a possible manifestation of methotrexate hypersensitivity.
Large haemorrhagic and necrotic cutaneous lesions developed after two low dose (5 mg) methotrexate injections in a patient suffering from long standing rheumatoid arthritis. Differential clinical diagnosis included factitia dermatitis, infectious processes, pyoderma gangrenosum, rheumatoid neutrophilic dermatitis, necrotizing arteritis and vasculitis. Histological and direct immunofluorescent examinations of skin biopsies supported the diagnosis of leucocytoclastic vasculitis. We discuss the respective roles of methotrexate and rheumatoid arthritis in the outbreak of leucocytoclastic vasculitis. Hypersensitivity is strongly suspected.
Antirheumatic Agents↗
[Therapy of pruritus associated with skin diseases with the serotonin receptor antagonist ondansetron].
BACKGROUND: Pruritus is often a stressing symptom and a therapeutic challenge. We report our experience with the serotonin receptor antagonist ondansetron in the symptomatic treatment of pruritus accompanying various skin diseases. PATIENTS AND METHODS: The influence of ondansetron (8-12 mg orally per day) on pruritus was assessed in twelve patients with various skin disorders. The intensity of pruritus was quantitated daily by a visual analogue scale over the time period of one week before, during, and one week after treatment. RESULTS: Ondansetron decreased pruritus intensity in prurigo simplex (four patients), asteatotic eczema (two patients), parapsoriasis en plaques, and pruritus of unknown origin (one patient each). One of two patients with atopic dermatitis experienced relief, whereas no benefit was observed in urticaria factitia and notalgia paraesthetica (one patient each). CONCLUSIONS: Ondansetron may ameliorate the concomitant pruritus of some dermatologic diseases.
Administration, Oral↗